Statins and pancreatic cancer. - Test2 - elhamkhani - TriplyDB

Statins and pancreatic cancer.

Statins and pancreatic cancer.

http://www.wikidata.org/entity/Q33597969

about

Simvastatin Therapy for Drug Repositioning to Reduce the Risk of Prostate Cancer Mortality in Patients With Hyperlipidemia.Lipid metabolism and carcinogenesis, cancer development.

P2860

Q52603655-592F9217-1342-412C-AA27-1F22536B748C Q55405747-A77F4450-4B20-4A4A-8265-09CD3AAE6B46

P2860

Statins and pancreatic cancer.

http://www.wikidata.org/entity/Q33597969

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Statins and pancreatic cancer.

@ast

Statins and pancreatic cancer.

@en

type

label

Statins and pancreatic cancer.

@ast

Statins and pancreatic cancer.

@en

prefLabel

Statins and pancreatic cancer.

@ast

Statins and pancreatic cancer.

@en

P1433

Q33597969-C1E04FEB-57A3-40B4-BF00-ECDD69D83B14

P1476

Q33597969-2C3A2731-B337-4753-A33E-97F5DD09060E

P2093

Q33597969-10C63FF1-D8DC-4B48-8927-D6D9382B2C61

Q33597969-17E73AF8-B3D2-423D-B886-04EC583B07B6

Q33597969-22B652DC-98B3-4106-9DA3-AD7508474096

Q33597969-50B8699A-4E13-4BA4-A5F2-CDA44156A79D

Q33597969-8DAC095E-F53C-4FEB-ABE1-01A3D6F8A600

Q33597969-FA544ABF-F0FF-4119-B115-5C4382D4292B

P2860

Q33597969-06304972-D669-4D7A-BA4A-FB7FD5AECCA7

Q33597969-06CA7739-7CDC-485B-800B-8948A4D25B5E

Q33597969-1BC66FEE-7534-437C-8409-85B0423C130A

Q33597969-21CBA2A9-D09F-49D9-98E3-D10CC8ABD199

Q33597969-23E5CE13-D7D3-4BE3-B74F-DDEE3027C01A

Q33597969-27DD03BD-E321-4B5F-AC1B-3731F8951AEC

Q33597969-295DAD65-EA2E-4F01-ACF1-A0CE407D6C4B

Q33597969-2B3B8759-687A-44B9-BB8D-2744B1BD2626

Q33597969-2B417674-8C9C-4801-A123-9CDF1A8F48CD

Q33597969-315C0510-BAD6-446F-871F-FCCF9B8BC05E

P304

Q33597969-54342309-660D-4A9D-A974-CE5E49DCA695

P31

Q33597969-63C69F2C-624C-424E-B1FD-9AB087A35447

P356

Q33597969-1644350A-EE4C-4840-A8F6-520CD93590F8

P433

Q33597969-D9370868-434C-4192-A6E4-A3CF8CBCA9F1

P478

Q33597969-AD28DDC7-5D7D-41EB-AAC1-45D9BFD0E702

P577

Q33597969-B2C28ECE-BAC3-4199-98B1-4ECD48CD4EE5

P698

Q33597969-579FFB8B-A4CA-4A57-9DFA-35A17D733A88

P932

Q33597969-38F80805-8D9B-49CF-A617-F8E528FD1536

P356

P1433

Oncology Letters

P1476

Statins and pancreatic cancer.

@en

P2093

Andrew E Hendifar

http://www.w3.org/2001/XMLSchema#string

Emily Lin

http://www.w3.org/2001/XMLSchema#string

Esha Sachdev

http://www.w3.org/2001/XMLSchema#string

Jun Gong

http://www.w3.org/2001/XMLSchema#string

Lori A Robbins

http://www.w3.org/2001/XMLSchema#string

Monica M Mita

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Recent progress in pancreatic cancer

Cancer statistics, 2015

d-δ-Tocotrienol-mediated suppression of the proliferation of human PANC-1, MIA PaCa-2, and BxPC-3 pancreatic carcinoma cells

Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites

Pancreatic cancer

A triple combination of atorvastatin, celecoxib and tipifarnib strongly inhibits pancreatic cancer cells and xenograft pancreatic tumors

Body mass index, effect modifiers, and risk of pancreatic cancer: a pooled study of seven prospective cohorts.

Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

Statin use and risk of pancreatic cancer: a meta-analysis.

P304

1035-1040

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.5572

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28454210

http://www.w3.org/2001/XMLSchema#string

P932

5403279

http://www.w3.org/2001/XMLSchema#string